Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID‐19: A systematic review and meta‐analysis

BACKGROUND: Patients with diabetes are more likely to suffer COVID‐19 complications. Using noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved challenging. In this study, we evaluate different noninsulin AGMs in patients with COVID‐19. METHODS: We searched Medline, E...

Descripción completa

Detalles Bibliográficos
Autores principales: Nassar, Mahmoud, Abosheaishaa, Hazem, Singh, Awadhesh Kumar, Misra, Anoop, Bloomgarden, Zachary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Editor's Recommendation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934962/
https://www.ncbi.nlm.nih.gov/pubmed/36690377
http://dx.doi.org/10.1111/1753-0407.13359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934962/
https://www.ncbi.nlm.nih.gov/pubmed/36690377
http://dx.doi.org/10.1111/1753-0407.13359

Ejemplares similares